Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 57 of 1714:
47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67
Gene Compound Assay Inh Ic50 Ki View
calcium channel, voltage-dependent, gamma subunit 7 RESERPINE Calcium Channel Type L, Benzothiazepine 79% 3.707uM 3.295uM View
calcium channel, voltage-dependent, gamma subunit 6 RESERPINE Calcium Channel Type L, Benzothiazepine 79% 3.707uM 3.295uM View
calcium channel, voltage-dependent, gamma subunit 5 RESERPINE Calcium Channel Type L, Benzothiazepine 79% 3.707uM 3.295uM View
calcium channel, voltage-dependent, gamma subunit 4 RESERPINE Calcium Channel Type L, Benzothiazepine 79% 3.707uM 3.295uM View
sodium channel, voltage-gated, type IV, beta BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel associated protein 1 BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel associated protein 2 BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type III, beta BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type I, alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type IX, alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type VII, alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
amiloride-sensitive cation channel 5, intestinal BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type III, beta BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type XI, alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type I, beta BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type 10, alpha polypeptide BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type IV, alpha polypeptide BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type V, alpha polypeptide BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, voltage-gated, type II, beta BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, nonvoltage-gated 1 alpha BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, nonvoltage-gated 1 gamma BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
sodium channel, nonvoltage-gated 1 beta BUTENAFINE Sodium Channel, Site 2 79% 2.9397uM 2.6818uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, gamma subunit 8 DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, gamma subunit 7 DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, gamma subunit 6 DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, gamma subunit 5 DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, gamma subunit 4 DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, gamma subunit 3 DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, gamma subunit 2 DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, gamma subunit 1 DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, beta 4 subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, beta 3 subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, beta 2 subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
calcium channel, voltage-dependent, alpha 1F subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Phenylalkylamine 82% 3.805uM 3.699uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 DEXCHLORPHENIRAMINE Adrenergic, Norepinephrine Transporter 82% 4.966uM 4.925uM View
cholinergic receptor, muscarinic 5 SULCONAZOLE Muscarinic M5 82% 2.607uM 1.873uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) DANAZOL CYP450-2C9 Inhibition 82% .3uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 DANAZOL CYP450-2C9 Inhibition 82% .3uM NoneNone View
Protein-tyrosine kinase, Fyn MIFEPRISTONE Protein Tyrosine Kinase, Fyn 82% 21.357uM NoneNone View
Cytochrom P450-1A2 monooxygenase ALOSETRON CYP450-1A2 Inhibition 82% .6047uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 ETHINYLESTRADIOL Dopamine Transporter 82% .559uM .444uM View
monoamine oxidase A AMILORIDE Monoamine Oxidase MAOA 82% 3.909uM NoneNone View
monoamine oxidase A AMILORIDE Monoamine Oxidase MAOA 82% 3.909uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 CELECOXIB Adrenergic, Norepinephrine Transporter 82% 7.308uM 7.247uM View
5-hydroxytryptamine (serotonin) receptor 5B DOXORUBICIN Serotonin 5-HT4 82% 12.468uM 2.078uM View
5-hydroxytryptamine (serotonin) receptor 4 DOXORUBICIN Serotonin 5-HT4 82% 12.468uM 2.078uM View
caspase 1 RIFAMPIN Protease, Caspase 1 82% 8.319uM NoneNone View
caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase) RIFAMPIN Protease, Caspase 1 82% 8.319uM NoneNone View
caspase 3, apoptosis related cysteine protease RIFAMPIN Protease, Caspase 1 82% 8.319uM NoneNone View
caspase 2 RIFAMPIN Protease, Caspase 1 82% 8.319uM NoneNone View
caspase 7 RIFAMPIN Protease, Caspase 1 82% 8.319uM NoneNone View
caspase 6 RIFAMPIN Protease, Caspase 1 82% 8.319uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Adrenergic, Norepinephrine Transporter 82% 1.27uM 1.26uM View
calcium channel, voltage-dependent, gamma subunit 8 AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
calcium channel, voltage-dependent, gamma subunit 7 AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
calcium channel, voltage-dependent, gamma subunit 6 AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
calcium channel, voltage-dependent, gamma subunit 5 AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
calcium channel, voltage-dependent, gamma subunit 4 AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
calcium channel, voltage-dependent, gamma subunit 3 AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
calcium channel, voltage-dependent, gamma subunit 2 AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
calcium channel, voltage-dependent, gamma subunit 1 AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
calcium channel, voltage-dependent, beta 4 subunit AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
calcium channel, voltage-dependent, beta 3 subunit AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
calcium channel, voltage-dependent, beta 2 subunit AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
calcium channel, voltage-dependent, alpha 1F subunit AMITRIPTYLINE Calcium Channel Type L, Benzothiazepine 82% 1.992uM 1.771uM View
adrenergic receptor, alpha 2c (Non-specific probe) METERGOLINE Imidazoline I2, Central 82% 1.923uM 1.282uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel, voltage-gated, type IV, beta TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel, voltage-gated, type IV, alpha TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel, voltage-gated, type III, alpha TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel, voltage-gated, type II, beta TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel, voltage-gated, type II, alpha 2 TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel, voltage-gated, type I, beta TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel, voltage-gated, type I, alpha TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel, voltage-gated, type IV, beta TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel associated protein 1 TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel associated protein 2 TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel, voltage-gated, type III, beta TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel, voltage-gated, type I, alpha TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel, voltage-gated, type IX, alpha TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
sodium channel, voltage-gated, type VII, alpha TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
amiloride-sensitive cation channel 5, intestinal TRIHEXYPHENIDYL Sodium Channel, Site 2 80% 2.797uM 2.552uM View
calcium channel, voltage-dependent, alpha 1F subunit QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, beta 1 subunit QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, gamma subunit 8 QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, gamma subunit 7 QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, gamma subunit 6 QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, gamma subunit 5 QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, gamma subunit 4 QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, gamma subunit 3 QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, gamma subunit 2 QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, gamma subunit 1 QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, beta 4 subunit QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, beta 3 subunit QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, beta 2 subunit QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit QUINACRINE Calcium Channel Type L, Phenylalkylamine 80% .739uM .719uM View
5-hydroxytryptamine (serotonin) receptor 2A SERTRALINE Serotonin 5-HT2A 80% 2.7409uM .7831uM View
calcium channel, voltage-dependent, gamma subunit 8 SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, gamma subunit 7 SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, gamma subunit 6 SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, gamma subunit 5 SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, gamma subunit 4 SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, gamma subunit 3 SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, gamma subunit 2 SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, gamma subunit 1 SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, beta 4 subunit SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, beta 3 subunit SAQUINAVIR Calcium Channel Type L, Benzothiazepine 80% 10.905uM 9.693uM View
calcium channel, voltage-dependent, gamma subunit 7 SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, gamma subunit 6 SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, gamma subunit 5 SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, gamma subunit 4 SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, gamma subunit 3 SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, gamma subunit 2 SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, gamma subunit 1 SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, beta 4 subunit SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, beta 3 subunit SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, beta 2 subunit SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, alpha 1F subunit SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, beta 1 subunit SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 SULOCTIDIL Calcium Channel Type L, Phenylalkylamine 79% .5251uM .5105uM View
adrenergic receptor, alpha 2b HEXACHLOROPHENE Adrenergic alpha2C 79% 6.9754uM 1.0135uM View
adrenergic receptor, alpha 2c (Non-specific probe) HEXACHLOROPHENE Adrenergic alpha2C 79% 6.9754uM 1.0135uM View
5-hydroxytryptamine (serotonin) receptor 2B DOMPERIDONE Serotonin 5-HT2B 79% 2.6uM 1.655uM View
5-hydroxytryptamine (serotonin) receptor 1A PROPAFENONE Serotonin 5-HT1A 79% 1.637uM .935uM View
mu-opioid receptor MOR FLUNARIZINE Opiate mu 79% 5.236uM 2.125uM View
adrenergic receptor, alpha 2a CYCLIZINE Imidazoline I2, Central 79% 3.132uM 2.088uM View
adrenergic receptor, alpha 2c (Non-specific probe) CYCLIZINE Imidazoline I2, Central 79% 3.132uM 2.088uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 DESLORATADINE Dopamine Transporter 79% 3.879uM 3.082uM View
calcium channel, voltage-dependent, beta 3 subunit DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, beta 2 subunit DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, alpha 1F subunit DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, beta 1 subunit DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, gamma subunit 8 DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, gamma subunit 7 DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, gamma subunit 6 DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, gamma subunit 5 DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, gamma subunit 4 DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, gamma subunit 3 DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, gamma subunit 2 DESLORATADINE Calcium Channel Type L, Phenylalkylamine 79% 2.786uM 2.708uM View
calcium channel, voltage-dependent, gamma subunit 8 PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, gamma subunit 7 PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, gamma subunit 6 PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, gamma subunit 5 PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, gamma subunit 4 PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, gamma subunit 3 PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, gamma subunit 2 PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
calcium channel, voltage-dependent, gamma subunit 1 PENTAMIDINE Calcium Channel Type L, Benzothiazepine 82% 2.208uM 1.963uM View
5-hydroxytryptamine (serotonin) receptor 2B PRAZOSIN Serotonin 5-HT2B 82% 4.118uM 2.621uM View
calcium channel, voltage-dependent, gamma subunit 8 PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, gamma subunit 7 PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, gamma subunit 6 PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, gamma subunit 5 PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, gamma subunit 4 PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, gamma subunit 3 PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, gamma subunit 2 PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, gamma subunit 1 PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, beta 4 subunit PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, beta 3 subunit PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, beta 2 subunit PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, alpha 1F subunit PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, beta 1 subunit PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PROCHLORPERAZINE Calcium Channel Type L, Phenylalkylamine 82% 1.205uM 1.172uM View
adrenergic receptor, alpha 2a 4-NONYLPHENOL Adrenergic alpha2A 82% 6.78uM 2.543uM View
sodium channel associated protein 1 GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel associated protein 2 GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type III, beta GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type I, alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type IX, alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
sodium channel, voltage-gated, type VII, alpha GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View
amiloride-sensitive cation channel 5, intestinal GUANABENZ Sodium Channel, Site 2 82% 3.591uM 3.276uM View